Sodium-glucose cotransporter-2 inhibitors and gastrointestinal neoplasm risk in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
- DOI
- 10.1007/s10238-026-02300-6
- Published
- 2026-09-03
- Container
- Clin Exp Med
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10238-026-02300-6,
title = {Sodium-glucose cotransporter-2 inhibitors and gastrointestinal neoplasm risk in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.},
author = {Zhang YF and Xie JJ and Wu Q and Zhou XY and Zeng C and Zeng Y and He YM and Guo M and Teng FY and Xu Y.},
year = {2026},
journal = {Clin Exp Med},
doi = {10.1007/s10238-026-02300-6},
url = {https://doi.org/10.1007/s10238-026-02300-6}
}RIS
TY - JOUR TI - Sodium-glucose cotransporter-2 inhibitors and gastrointestinal neoplasm risk in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. AU - Zhang YF AU - Xie JJ AU - Wu Q AU - Zhou XY AU - Zeng C AU - Zeng Y AU - He YM AU - Guo M AU - Teng FY AU - Xu Y. PY - 2026 JO - Clin Exp Med DO - 10.1007/s10238-026-02300-6 UR - https://doi.org/10.1007/s10238-026-02300-6 ER -
APA
YF, Z., JJ, X., Q, W., XY, Z., C, Z., Y, Z., YM, H., M, G., FY, T., & Y., X. (2026). Sodium-glucose cotransporter-2 inhibitors and gastrointestinal neoplasm risk in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.. Clin Exp Med. https://doi.org/10.1007/s10238-026-02300-6
Source records
- europe-pmc · retrieved 2026-09-27T08:41:27.586Z